Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006

Gui Liu; Elizabeth R Unger; Susan Hariri; Martin Steinau; Lauri E Markowitz

doi:10.1097/OLQ.0000000000000492

Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006

Sex Transm Dis. 2016 Oct;43(10):633-6. doi: 10.1097/OLQ.0000000000000492.

Authors

Gui Liu¹, Elizabeth R Unger, Susan Hariri, Martin Steinau, Lauri E Markowitz

Affiliation

¹ From the Centers for Disease Control and Prevention, Atlanta, GA.

PMID: 27631358
DOI: 10.1097/OLQ.0000000000000492

Abstract

Before any vaccine introduction, overall DNA prevalence of any 9-valent human papillomavirus (9vHPV) types, HPV 31/33/45/52/58, and HPV 16/18 was 16.0%, 9.5%, and 6.2%, respectively, among female participants in National Health and Nutrition Examination Survey. Non-Hispanic black females were more likely to have infection with HPV 31/33/45/52/58, but not HPV 16/18, compared to non-Hispanic white females.

MeSH terms

Adolescent
Adult
Cotinine / blood
Ethnicity
Female
Human papillomavirus 16 / classification
Human papillomavirus 16 / genetics
Human papillomavirus 16 / immunology
Human papillomavirus 18 / classification
Human papillomavirus 18 / genetics
Human papillomavirus 18 / immunology
Humans
Middle Aged
Nutrition Surveys
Papillomaviridae / classification
Papillomaviridae / genetics
Papillomaviridae / immunology*
Papillomavirus Infections* / epidemiology
Papillomavirus Infections* / ethnology
Papillomavirus Infections* / virology
Papillomavirus Vaccines / immunology*
Prevalence
Self Report
Sexual Partners
Young Adult

Substances

Papillomavirus Vaccines
Cotinine